有症状但冠状动脉支架通畅患者中低剂量动态CT心肌灌注成像检出的心肌血流减低患病率
前瞻性纳入37例有症状但支架通畅且无阻塞性新发病变的患者,行低剂量动态CT心肌灌注成像,以MBFratio 0.85为阈值,发现48.6%(18/37)患者支架血管供血区存在心肌低灌注,低灌注区平均MBF和心肌血容量均显著低于无低灌注区,临床参数在两组间无显著差异。
要点
- 有症状且支架通畅患者中,动态CT-MPI检出支架血管供血区心肌低灌注的比例为48.6%(18/37)。
- 以MBFratio 0.85为阈值区分低灌注与无低灌注节段,低灌注区平均MBF和心肌血容量均显著降低。
- 低灌注组与无低灌注组之间各项临床参数均无统计学显著差异。
核心结论
- 有症状患者经皮冠状动脉介入治疗后尽管支架通畅,心肌血流减低仍常见,低剂量动态CT-MPI可检出。
研究设计与样本
- 前瞻性研究,连续纳入37例有症状、支架通畅且无阻塞性新发病变的患者,采用第三代双源CT行动态CT-MPI, shuttle-mode采集覆盖整个左心室,对比剂为碘普罗胺370 mg碘/mL 50 mL以6 mL/s经肘静脉注射后40 mL生理盐水冲管。
关键影像表现/征象
- 支架血管供血区平均MBF减低见于19处病变和81个节段。
- 低灌注支架血管供血区平均MBF为77.5 ± 16.6 mL/100 mL/min,无低灌注支架血管供血区为140.4 ± 24.1 mL/100 mL/min(p < 0.001)。
- 低灌注支架血管供血区心肌血容量为6.4 ± 3.7 mL/100 mL,无低灌注支架血管供血区为11.5 ± 4 mL/100 mL(p < 0.001)。
诊断标准与关键数值
- MBFratio定义为整个支架血管供血区平均MBF值与整个参考供血区平均MBF值之比。
- 以MBFratio 0.85为截断值区分低灌注与无低灌注节段。
临床应用与阅片要点
- 对支架置入后有症状但支架通畅的患者,动态CT-MPI可定量评估支架血管供血区心肌血流。
- 动态CT-MPI平均有效剂量为3.1 ± 1.2 mSv(范围1.7-6.3 mSv)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To study the prevalence and clinical characteristics of decreased myocardial blood flow (MBF) quantified by dynamic computed tomography (CT) myocardial perfusion imaging (MPI) in symptomatic patients without in-stent restenosis.
MATERIALS AND METHODS: Thirty-seven (mean age, 71.3 ± 10 years; age range, 48-88 years; 31 males, 6 females) consecutive symptomatic patients with patent coronary stents and without obstructive de novo lesions were prospectively enrolled to undergo dynamic CT-MPI using a third-generation dual-source CT scanner. The shuttle-mode acquisition technique was used to image the complete left ventricle. A bolus of contrast media (50 mL; iopromide, 370 mg iodine/mL) was injected into the antecubital vein at a rate of 6 mL/s, followed by a 40-mL saline flush. The mean MBF value and other quantitative parameters were measured for each segment of both stented-vessel territories and reference territories. The MBFratio was defined as the ratio of the mean MBF value of the whole stent-vessel territory to that of the whole reference territory. An MBFratio of 0.85 was used as the cut-off value to distinguish hypoperfused from non-hypoperfused segments.
RESULTS: A total of 629 segments of 37 patients were ultimately included for analysis. The mean effective dose of dynamic CT-MPI was 3.1 ± 1.2 mSv (range, 1.7-6.3 mSv). The mean MBF of stent-vessel territories was decreased in 19 lesions and 81 segments. Compared to stent-vessel territories without hypoperfusion, the mean MBF and myocardial blood volume were markedly lower in hypoperfused stent-vessel territories (77.5 ± 16.6 mL/100 mL/min vs. 140.4 ± 24.1 mL/100 mL/min [p < 0.001] and 6.4 ± 3.7 mL/100 mL vs. 11.5 ± 4 mL/100 mL [p < 0.001, respectively]). Myocardial hypoperfusion in stent-vessel territories was present in 48.6% (18/37) of patients. None of clinical parameters differed statistically significantly between hypoperfusion and non-hypoperfusion subgroups.
CONCLUSION: Decreased MBF is commonly present in patients who are symptomatic after percutaneous coronary intervention, despite patent stents and can be detected by dynamic CT-MPI using a low radiation dose.
引用
- Li Y, Yuan M, Yu M, et al. Prevalence of Decreased Myocardial Blood Flow in Symptomatic Patients with Patent Coronary Stents: Insights from Low-Dose Dynamic CT Myocardial Perfusion Imaging. Korean J Radiol. 2019. PMID: 30887744. doi:10.3348/kjr.2018.0399
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。